Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huizhisu (Huizhi Kangyuan)
- Development stage
- Unknown
- Lead developer
- Beijing Anding Hospital
- Modality
- Small Molecules
01
Overview
Huizhisu is a combination product primarily composed of phosphatidylserine (PS), docosahexaenoic acid (DHA), and taurine, which is investigated in China for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and cognitive enhancement. Phosphatidylserine is a critical phospholipid in neuronal membranes that supports membrane fluidity and serves as a cofactor for enzymes like protein kinase C. DHA is an omega-3 fatty acid essential for brain structure and function, while taurine acts as a neuromodulator and antioxidant. The combination is hypothesized to improve symptoms of ADHD by modulating neurotransmitter systems, including dopamine and acetylcholine, and enhancing neuronal signaling. Clinical trials, such as those conducted at Beijing Anding Hospital, have evaluated Huizhisu as a non-stimulant therapeutic option for children with ADHD.
- Brand names
- Huizhisu
- Other names
- 慧智素Hui Zhi Su
02
Targets
Glycine receptorPKC (Protein kinase C family)
Beyond the preview
Go deeper on Huizhisu (Huizhi Kangyuan).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huizhisu (Huizhi Kangyuan).